Literature DB >> 2175025

Isoforms of mammalian cytochrome c oxidase: correlation with human cytochrome c oxidase deficiency.

N G Kennaway1, R D Carrero-Valenzuela, G Ewart, V K Balan, R Lightowlers, Y Z Zhang, B R Powell, R A Capaldi, N R Buist.   

Abstract

We have reviewed the structure, function, and biogenesis of mammalian cytochrome c oxidase, examined the tissue-specific expression of isoforms of cytochrome c oxidase subunits in different mammals, and attempted to correlate the data with our knowledge of cytochrome c oxidase deficiency, illustrated by one particular patient. Cytochrome c oxidase was isolated from bovine tissues, and individual subunits examined by SDS-PAGE, N-terminal peptide sequencing, and antibody binding. Isoforms of subunits VIa, VIIa, and VIII were identified, manifesting one pattern of expression in heart and skeletal muscle, and another in liver, kidney, and brain. In rat heart and liver, only one form of subunit VIIa was identified. Northern analysis of bovine and rat tissues suggested that the tissue-specific expression of subunits VIa and VIII is regulated transcriptionally in liver, kidney, and brain, and posttranscriptionally in heart and skeletal muscle. In humans, antibody binding documented isoforms of subunits VIa and VIIa, with the pattern of expression in heart and skeletal muscle differing from that in liver, kidney, and brain; our data suggested that both isoforms of subunit VIa may be expressed in human heart. In a patient with cytochrome c oxidase deficiency, the clinical, morphologic, and biochemical manifestations were much more severe in heart than in skeletal muscle. Antibody binding suggested partial assembly of the enzyme in heart. These and other data suggest considerably more variability in the tissue-specific expression of isoforms of cytochrome c oxidase subunits than previously recognized.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2175025     DOI: 10.1203/00006450-199011000-00024

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  10 in total

1.  Cytochrome c oxidase III as a mechanism for apoptosis in heart failure following myocardial infarction.

Authors:  Changgong Wu; Lin Yan; Christophe Depre; Sunil K Dhar; You-Tang Shen; Junichi Sadoshima; Stephen F Vatner; Dorothy E Vatner
Journal:  Am J Physiol Cell Physiol       Date:  2009-07-22       Impact factor: 4.249

2.  Multiple respiratory chain abnormalities associated with hypertrophic cardiomyopathy and 3-methylglutaconic aciduria.

Authors:  H Ibel; W Endres; H B Hadorn; T Deufel; I Paetzke; M Duran; N G Kennaway; K M Gibson
Journal:  Eur J Pediatr       Date:  1993-08       Impact factor: 3.183

3.  Mutations in COX15 produce a defect in the mitochondrial heme biosynthetic pathway, causing early-onset fatal hypertrophic cardiomyopathy.

Authors:  Hana Antonicka; Andre Mattman; Christopher G Carlson; D Moira Glerum; Kristen C Hoffbuhr; Scot C Leary; Nancy G Kennaway; Eric A Shoubridge
Journal:  Am J Hum Genet       Date:  2002-12-09       Impact factor: 11.025

4.  Influence of thyroid hormone on the tissue-specific expression of cytochrome c oxidase isoforms during cardiac development.

Authors:  J Meehan; J M Kennedy
Journal:  Biochem J       Date:  1997-10-01       Impact factor: 3.857

5.  Control of mitochondrial membrane potential and ROS formation by reversible phosphorylation of cytochrome c oxidase.

Authors:  Icksoo Lee; Elisabeth Bender; Bernhard Kadenbach
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

6.  Liver cytochrome c oxidase deficiency in a case of neonatal-onset hepatic failure.

Authors:  P Edery; B Gérard; D Chretien; A Rötig; R Cerrone; D Rabier; C Rambaud; M Fabre; J M Saudubray; A Munnich
Journal:  Eur J Pediatr       Date:  1994-03       Impact factor: 3.183

7.  Characterization of a novel cardiac isoform of the cell cycle-related kinase that is regulated during heart failure.

Authors:  Hongyu Qiu; Huacheng Dai; Komal Jain; Rina Shah; Chull Hong; Jayashree Pain; Bin Tian; Dorothy E Vatner; Stephen F Vatner; Christophe Depre
Journal:  J Biol Chem       Date:  2008-05-28       Impact factor: 5.157

8.  Immunohistochemical analysis of muscle cytochrome c oxidase deficiency in children.

Authors:  S Possekel; A Lombes; H Ogier de Baulny; M A Cheval; M Fardeau; B Kadenbach; N B Romero
Journal:  Histochem Cell Biol       Date:  1995-01       Impact factor: 4.304

9.  Neuroprotective potential of ketamine prevents developing brain structure impairment and alteration of neurocognitive function induced via isoflurane through the PI3K/AKT/GSK-3β pathway.

Authors:  Ruiwei Wang; Zihao Zhang; Mukesh Kumar; Guangming Xu; Mengyuan Zhang
Journal:  Drug Des Devel Ther       Date:  2019-02-04       Impact factor: 4.162

Review 10.  Down the Iron Path: Mitochondrial Iron Homeostasis and Beyond.

Authors:  Jonathan V Dietz; Jennifer L Fox; Oleh Khalimonchuk
Journal:  Cells       Date:  2021-08-25       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.